Quercetin attenuates atherosclerotic inflammation and adhesion molecule expression by modulating TLR-NF-κB signaling pathway

Cellular Immunology

Volumn 310, Issue , 2016, Pages 131-140

  Bhaskar, Shobha ^a   Sudhakaran, P R ^a   Helen, A ^a  

^a UNIVERSITY OF KERALA   (India)

Author keywords

Adhesion molecule; Atherosclerosis; Cytokine; Inflammation; Quercetin; TLR

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROSTAGLANDIN SYNTHASE; QUERCETIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; VASCULAR CELL ADHESION MOLECULE 1; ANTIINFLAMMATORY AGENT; AUTACOID; LOW DENSITY LIPOPROTEIN; TLR2 PROTEIN, RAT; TLR4 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXPERIMENTAL ATHEROSCLEROSIS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; INFLAMMATION; LEUKOCYTE ADHERENCE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; ATHEROGENIC DIET; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; SPRAGUE DAWLEY RAT; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ATHEROSCLEROSIS; DIET, ATHEROGENIC; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LIPOPROTEINS, LDL; NF-KAPPA B; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84994184220     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2016.08.011     Document Type: Article

References (59)

1. [1] Ross, R., Atherosclerosis – an inflammatory disease. N. Eng. J. Med. 340 (1999), 115–126.
2. [2] Leitinger, N., Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr. Opin. Lipidol. 14 (2003), 421–430.
3. [3] Peiser, L., Mukhopadhyay, S., Gordon, S., Scavenger receptors in innate immunity. Curr. Opin. Immunol. 14 (2002), 123–128.
4. [4] Janeway, C.A. Jr, Medzhitov, R., Innate immune recognition. Annu. Rev. Immunol. 20 (2002), 197–216.
5. [5] Lee, J.Y., Hwang, D.H., The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol. Cells 21 (2006), 174–185.
6. [6] Lee, J.Y., Zhao, L., Hwang, D.H., Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids. Nutr. Rev. 68 (2010), 38–61.
7. [7] Beutler, B., Inferences, questions and possibilities in Toll-like receptor signaling. Nature 430 (2004), 257–263.
8. [8] Mullick, A.E., Soldau, K., Kiosses, W.B., Bell, T.A. III, Tobias, P.S., Curtiss, L.K., Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J. Exp. Med. 205:2 (2008), 373–383.
9. [9] Kuwahata, S., Fujita, S., Orihara, K., Hamasaki, S., Oba, R., Hirai, H., Nagata, K., Ishida, S., Kataoka, T., Oketani, N., Ichiki, H., Iriki, Y., Saihara, K., Okui, H., Ninomiya, Y., Tei, C., High expression level of Toll-like receptor 2 on monocytes is an important risk factor for arteriosclerotic disease. Atherosclerosis 209:1 (2010), 248–254.
10. [10] Bzowska, M., Nogieć, A., Skrzeczyńska-Moncznik, J., Mickowska, B., Guzik, K., Pryjma, J., Oxidized LDLs inhibit TLR-induced IL-10 production by monocytes: a new aspect of pathogen-accelerated atherosclerosis. Inflammation 35:4 (2012), 1567–1584.
11. [11] Paolillo, R., Iovene, M.R., Carratelli, C.R., Rizzo, A., Induction of VEGF and MMP-9 expression by toll-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumonia. Int. J. Immunopathol. Pharmacol. 5:2 (2012), 377–386.
12. [12] Zhang, X.P., Zhang, L., Chen, L.J., Cheng, Q.H., Wang, J.M., Cai, W., Shen, H.P., Cai, J., Influence of dexamethasone on inflammatory mediators and NF-kappaB expression in multipleorgans of rats with severe acute pancreatitis. World J. Gastroenterol. 13:4 (2007), 548–556.
13. [13] Libby, P., Inflammation in atherosclerosis. Nature 420 (2002), 868–874.
14. [14] Hansson, G.K., Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 (2005), 1685–1695.
15. [15] Liu, Z.Q., Yu, W., Liu, Z.L., Antioxidative and prooxidative effects of coumarin derivatives on free radical initiated and photosensitized peroxidation of human low-density lipoprotein. Chem. Phys. Lipids 103 (1999), 125–135.
16. [16] Koga, T., Meydani, M., Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am. J. Clin. Nutr. 73:5 (2001), 941–948.
17. [17] Boots, A.W., Haenen, G.R., Bast, A., Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 585 (2008), 325–337.
18. [18] Havel, R.J., Eder, H.A., Bragdon, J.H., The distribution and chemical composition of ultracentrifugally separated lipoprotein in human serum. J. Clin. Invest. 34 (1995), 1345–1353.
19. [19] Thao, N.K., Ziad, A.M., Sarsat, V.W., Canteloup, S., Latscha, B.D., Oxidized low density lipoprotein induces macrophage respiratory burst via its protein moiety: a novel pathway in atherogenesis. Biochem. Biophys. Res. Commun. 263 (1999), 804–809.
20. [20] Jaffe, E.A., Nachman, R.L., Becker, C.G., Minick, C.R., Culture of human endothelial cells derived from umbilical veins – identification by morphologic and immunologic criteria. J. Clin. Invest. 52 (1973), 2745–2756.
21. [21] Engvall, E., Perlman, P., Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8 (1971), 871–874.
22. [22] Huch, H.Y., Pearce, S.F., Tersner, J.M., Schindler, I.L., Silverstein, R.L., Regulated expression of CD36 in foam cell formation. Blood 87 (1996), 2020–2025.
23. [23] Shimizu, T., Kondo, K., Hayaishi, O., Role of prostaglandin endoperoxidases in the serum thiobarbituric acid reaction. Arch. Biochem. Biophys. 206 (1984), 271–276.
24. [24] Axelrod, B., Cheesebrough, T.M., Laakso, S., Lipoxygenase from soyabean. Methods Enzymol. 71 (1981), 441–445.
25. [25] Bradley, P.P., Priebat, D.A., Christensen, R.D., Rothstein, G., Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Darmatol. 78 (1982), 206–209.
26. [26] Salter, M., Knowles, R.G., Assay of NOS activity by the measurements of conversion of oxyhemoglobin to methemoglobin by NO. Titheradge, M.A., (eds.) Methods in Molecular Biology Nitric Oxide Protocol TOTOWA, 100, 1997, Humana press, NJ, 61–65.
27. [27] Lowry, O.H., Roseburgh, N.J., Farr, A.L., Randall, R.J., Protein measurement with Folin phenol reagent. J. Biol. Chem. 193 (1951), 265–275.
28. [28] Huang, A.L., Vita, J.A., Effects of systemic inflammation on endothelium-dependent vasodilatation. Trends Cardiovasc. Med. 16 (2006), 15–20.
29. [29] Zhu, G.D., Arendsen, D.L., Gunawardana, I.W., Boyd, S.A., Stewart y cols, A.O., Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxythieno(2,3-c)pyridines with fine-tunning at C-2 carbamides. J. Med. Chem. 11 (2001), 3469–3487.
30. [30] Bevilacqua, M.P., Pober, J.S., Wheeler, M.E., Cotran, R.S., Gimbrone, M.A. Jr., Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J. Clin. Invest. 76 (1985), 2003–2011.
31. [31] Manning, A.M., Bell, F.P., Rosenbloom, C.L., Chosay, J.G., Simmons, C.A., Northrup, J.L., Shebuski, R.J., Dunn, C.J., Anderson, D.C., NF-κB is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment. J. Inflamm. 45 (1995), 283–296.
32. [32] Chao, P.Y., Huang, Y.P., Hsieh, W.B., Inhibitive effect of purple sweet potato leaf extract and its components on cell adhesion and inflammatory response in human aortic endothelial cells. Cell Adh. Migr. 7:2 (2013), 237–245.
33. [33] Kobuchi, H., Roy, S., Sen, C.K., Nguyen, H.G., Packer, L., Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am. J. Physiol. 277 (1999), C403–C411.
34. [34] Kleemann, R., Verschuren, L., Morrison, M., Zadelaar, S., VanEr, M.J., Wielinga, P.Y., Kooistra, T., Antiinflammatory, antiproliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 218:1 (2011), 44–52.
35. [35] Tribolo, S., Lodi, F., Connor, C., Suri, S., Wilson, V.G., Taylor, M.A., Needs, P.W., Kroon, P.A., Hughes, D.A., Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 197:1 (2008), 50–56.
36. [36] Panicker, S.R., Sreenivas, P., Babu, M.S., Karunagaran, D., Kartha, C.C., Quercetin attenuates monocyte chemoattractant protein-1 gene expression in glucose primed aortic endothelial cells through NF-kappaB and AP-1. Pharmacol. Res. 62:4 (2010), 328–336.
37. [37] Chen, P., Shi, Q., Xu, X., Wang, Y., Chen, W., Wang, H., Quercetin suppresses NF-κB and MCP-1 expression in a high glucose-induced human mesangial cell proliferation model. Int. J. Mol. Med. 30:1 (2012), 119–125.
38. [38] Collins, T., Endothelial nuclear factor-kappaB and the initiation of the atherosclerotic lesion. Lab. Invest. 68 (1993), 499–508.
39. [39] Bowie, A., O'Neill, L.A.J., Oxidative stress and nuclear factor kappa B activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59 (2000), 13–23.
40. [40] Maziere, C., Auclair, M., Djavaheri-Mergny, M., Packer, L., Maziere, J.C., Oxidized low density lipoprotein induces activation of the transcription factor NF-κB in fibroblasts, endothelial and smooth muscle cells. Biochem. Mol. Biol. Int. 39 (1996), 1201–1207.
41. [41] Hernan dez-Presa, M., Bustos, C., Ortego, M., Renedo, G., Ruiz-Ortega, M., Egido, J., Angiotensin-converting enzyme inhibitor prevents arterial nuclear factor-kB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95 (1997), 1532–1541.
42. [42] Peet, G.W., Li, J., I kappaB kinase alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin. J. Biol. Chem. 274 (1999), 32655–32661.
43. [43] Yoshizumi, M., Tsuchiya, K., Suzaki, Y., Kirima, K., Kyaw, M., Moon, J.H., Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem. Biophys. Res. Commun. 293 (2002), 1458–1465.
44. [44] Miller, Y.I., Viriyakosol, S., Worrall, D.S., Boullier, A., Butler, S., Witztum, J.L., Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler. Thromb. Vasc. Biol. 25 (2005), 1213–1219.
45. [45] Wolowczuk, I., Verwaerde, C., Viltart, O., Delanoye, A., Delacre, M., Pot, B., Grangette, C., Feeding our immune system: impact on metabolism. Clin. Develop. Immunol., 2008, 10.1155/2008/639803 Article ID: 639803.
46. [46] Edfeldt, K., Swedenborg, J., Hansson, G.K., Yan, Z., Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105 (2002), 1158–1161.
47. [47] Bhaskar, S., Kumar, K.S., Krishnan, K., Antony, H., Quercetin alleviates hypercholesterolemic diet induced inflammation during progression and regression of atherosclerosis in rabbits. Nutrition 29:1 (2013), 219–229.
48. [48] Garcia-Mediavilla, V., Crespo, I., Collado, P.S., Estellar, A., Sanchez-Campos, S., Tunon, M.J., Gonzalez-Gallego, J., The anti-inflammatory flavones quercetin and Kaempherol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein and down-regulation of the nuclear factor kappa B pathway in Chang Liver cells. Eur. J. Pharmacol. 557 (2007), 221–229.
49. [49] Radmark, O., Samuelsson, B., 5-lipoxygenase: regulation and possible involvement in atherosclerosis. Prostaglandins Other Lipid Mediat. 83 (2007), 162–174.
50. [50] Mehrabian, M., Allayee, H., Wong, J., Shih, W., Wang, X.P., Shaposhnik, Z., Funk, C.D., Lusis, A.J., Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 91 (2002), 120–126.
51. [51] Davidge, S.T., Baker, P.N., McLaughlin, M.K., Roberts, J.M., Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ. Res. 77 (1995), 274–283.
52. [52] Bhaskar, S., Shalini, V., Helen, A., Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway. Immunobiology 216 (2011), 367–373.
53. [53] Flórez, S.M., Fernández, B.G., Campos, S.S., Gallego, J.G., Tuñón, M.J., Quercetin attenuates nuclear factor-κB activation and nitric oxide production in interleukin-1ß–activated rat hepatocytes. J. Nutr. 135 (2005), 1359–1365.
54. [54] Wong, N.D., Gransar, H., Narula, J., Shaw, L., Moon, J.H., Miranda-Peats, R., Rozanski, A., Hayes, S.W., Thomson, L.E.J., Friedman, J.D., Berman, D.S., Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events. J. Am. Coll. Cardiol. Img. 2 (2009), 1093–1099.
55. [55] Rice-Evans, A., Packer, L., Flavonoids in Health and Disease. 1998, Marcel Dekker Inc., New York.
56. [56] Liang, Y.J., Shyu, K.G., Wang, B.W., Lai, L.P., C-reactive protein activates the nuclear factor-κB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells. J. Mol. Cell Cardiol. 40 (2006), 412–420.
57. [57] Galkina, E., Ley, K., Immune and inflammatory mechanisms of atherosclerosis. Annu. Rev. Immunol. 27 (2009), 165–197.
58. [58] Zwaka, T.P., Hombach, V., Torzewski, J., C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103 (2001), 1194–1197.
59. [59] Venugopal, S.K., Devaraj, S., Jialal, J., Macrophage conditioned medium induces the expression of C-Reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am. J. Pathol. 166 (2005), 1265–1271.